|Title:||Intercountry consultation on combating counterfeit medicines : report of the intercountry meeting, New Delhi, India, 7-8 August 2008|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||This consultation was convened to provide information to Member countries on various issues such as definition, terminology and other factors relating to counterfeit medicines/medical products. It was widely perceived that counterfeit medicines is a problem in countries of the South-East Asia Region but the magnitude is unknown. The meeting shared country experiences on counterfeit medicines; reviewed the work of International Medical Products Anti-Counterfeiting Taskforce (IMPACT) in which WHO is the Secretariat, in combating counterfeit medical products and proposed a definition for counterfeit medicines/medical products. The focus of this definition was on the public health impact rather than on intellectual property violations. Recommendations for countries and for WHO have been made on dealing with counterfeit medicines/medical products.|
|Gov't Doc #:||SEA-Drugs-159|
|Appears in Collections:||Meeting Reports|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.